Mar 12, 2019
Portage Announces Change of Auditors
Feb 08, 2019
Portage Biotech Inc. - CSE to Issue Final Bulletin Regarding SalvaRx Acquisition
Jan 30, 2019
Portage provides updates on trading of its shares on OTC Markets
Jan 08, 2019
Shareholders approve Acquisition of SalvaRx Limited
Dec 19, 2018
Portage Provides Additional Information Relating to the Independent Director Review of the Proposed Acquisition of SalvaRx Limited
Dec 10, 2018
Further subscription of US$950,00 in Convertible Loan Notes to iOx Therapeutics
Dec 06, 2018
Portage Shares to Resume Trading; SalvaRx Acquisition Meeting Materials Mailed and Filed on SEDAR
Nov 27, 2018
Portage posts meeting materials; trading on CSE expected to resume shortly; overview of combined Portage/SalvaRx portfolio
Nov 21, 2018
Portage announces setting of meeting date to approve SalvaRx acquisition
Oct 22, 2018
Portage provides update on SalvaRx portfolio company, Intensity Therapeutics, Inc.
Oct 09, 2018
Portage provides update on proposed acquisition of SalvaRx
Aug 28, 2018
Portage Provides update on proposed acquisition of SalvaRx
Aug 14, 2018
Portage to Acquire SalvaRx Limited
Jun 04, 2018
Portage provides update on its associate, Stimunity S.A, a Paris-based cancer immunotherapy company
Mar 08, 2018
Portage invests in iOx Therapeutics, an United Kingdom-based cancer immunotherapy company
Feb 28, 2018
Portage invests in Stimunity S.A, a Paris-based cancer immunotherapy company
Feb 02, 2018
Portage 's PPL forms a joint venture with University of Glasgow to develop new peptide therapeutics
Jan 19, 2018
Portage completes distribution of stock dividend of Biohaven shares
Jan 04, 2018
Portage Provides Update on Their Declaration of Stock Dividend of Biohaven Shares
Dec 04, 2017
Portage Announces Declaration of Stock Dividend of Biohaven Shares and Fixes January 5, 2018 as the Record Date for the Distribution and January 15, 2018 as Distribution Date